Engineers Gate Manager LP Alkermes Plc. Transaction History

Engineers Gate Manager LP

$7.46 Billion
Q2 2025

A detailed history of Engineers Gate Manager LP transactions in Alkermes Plc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 47,594 shares of ALKS stock, worth $1.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

47,594

Previous 32,983 44.3%

Holding current value

$1.5 Million

Previous $1.09 Million 24.98%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$26.59 - $32.65 $388,506 - $477,049	14,611 Added 44.3%	47,594 $1.36 Million
Q1 2025 May 15, 2025	BUY	$28.08 - $36.0 $926,162 - $1.19 Million	32,983 New	32,983 $1.09 Million
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $834,779 - $1.04 Million	36,279 Added 379.09%	45,849 $1.28 Million
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $873,322 - $1.02 Million	-37,627 Reduced 79.72%	9,570 $230,000
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $861,405 - $1.06 Million	32,629 Added 223.98%	47,197 $1.28 Million
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $2.11 Million - $2.59 Million	-90,408 Reduced 86.12%	14,568 $404,000
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $1.64 Million - $1.93 Million	60,373 Added 135.36%	104,976 $2.94 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $880,098 - $1.04 Million	31,055 Added 229.22%	44,603 $1.4 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $623,714 - $715,139	-24,643 Reduced 64.53%	13,548 $381,000
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $1.08 Million - $1.3 Million	-49,392 Reduced 56.39%	38,191 $997,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $482,922 - $699,578	21,951 Added 33.45%	87,583 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $1.73 Million - $2 Million	65,632 New	65,632 $1.96 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $2.3 Million - $2.79 Million	-99,702 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $1.81 Million - $2.71 Million	84,326 Added 548.43%	99,702 $2.32 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $730,826 - $1 Million	-31,272 Reduced 67.04%	15,376 $474,000
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $882,735 - $1.18 Million	-47,004 Reduced 50.19%	46,648 $1.14 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $1.18 Million - $1.5 Million	-64,761 Reduced 40.88%	93,652 $1.75 Million
Q4 2020 Feb 16, 2021	BUY	$15.39 - $22.1 $2.03 Million - $2.92 Million	132,190 Added 504.1%	158,413 $3.16 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $553,673 - $707,852	-34,262 Reduced 56.65%	26,223 $435,000
Q2 2020 Aug 17, 2020	BUY	$13.31 - $19.41 $628,924 - $917,161	47,252 Added 357.08%	60,485 $1.17 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $2.77 Million - $4.51 Million	-212,268 Reduced 94.13%	13,233 $191,000
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $2.11 Million - $2.66 Million	122,142 Added 118.17%	225,501 $4.6 Million
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $2.01 Million - $2.5 Million	-103,011 Reduced 49.92%	103,359 $2.02 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $2.03 Million - $3.53 Million	94,656 Added 84.73%	206,370 $4.65 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $1.03 Million - $1.32 Million	-36,236 Reduced 24.49%	111,714 $4.08 Million
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $2.29 Million - $3.66 Million	82,054 Added 124.52%	147,950 $4.37 Million
Q3 2018 Nov 01, 2018	BUY	$38.6 - $46.12 $2.54 Million - $3.04 Million	65,896 New	65,896 $2.8 Million

Others Institutions Holding ALKS

# of Institutions

393

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.18B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Alkermes Plc. Transaction History